The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preventive HIPEC in combination with perioperative FLOT versus FLOT alone for resectable diffuse type gastric and gastroesophageal junction type II/III adenocarcinoma: The phase III “PREVENT” trial of the AIO /CAOGI /ACO.
 
Thorsten Oliver Goetze
Consulting or Advisory Role - Bayer; Lilly; MSD Oncology; Roche; SERVIER
Speakers' Bureau - Lilly
Research Funding - Deutsche Forschungsgemeinschaft; Deutsche Krebshilfe (Inst); Gemeinsamer Bundesausschuss
 
Pompiliu Piso
No Relationships to Disclose
 
Sylvie Lorenzen
No Relationships to Disclose
 
Ulli Simone Bankstahl
No Relationships to Disclose
 
Marcin Ostrzyzek
No Relationships to Disclose
 
Claudia Pauligk
No Relationships to Disclose
 
Timursah Habibzade
No Relationships to Disclose
 
Daniel Reim
Research Funding - Takeda (Inst)
Travel, Accommodations, Expenses - Takeda
 
Wolf Otto Bechstein
Honoraria - Astellas Pharma; Baxter; Chiesi; GORE; Integra LifeSciences; MCI Group; MCI Group; Medupdate; Merck Serono; Sanofi; Sirtex Medical; Teva
Consulting or Advisory Role - Astellas Pharma; Novartis
Speakers' Bureau - Integra LifeSciences
Travel, Accommodations, Expenses - Astellas Pharma; Baxter; Chiesi; Falk Foundation; GORE; Integra LifeSciences; MCI Deutschland; Medupdate; Merck Serono; Novartis; Sanofi; Sirtex Medical; Teva
 
Alfred Königsrainer
Research Funding - Rand Italy (Inst)
Travel, Accommodations, Expenses - Capnomed (Inst)
 
Stefan Paul Mönig
No Relationships to Disclose
 
Beate Rau
No Relationships to Disclose
 
Matthias Schwarzbach
No Relationships to Disclose
 
Salah-Eddin Al-Batran
Stock and Other Ownership Interests - Institut für Klinische Krebsforschung GmbH
Consulting or Advisory Role - Bristol-Myers Squibb; Immutep; Lilly; MacroGenics; Merck Sharp & Dohme
Speakers' Bureau - AIO gGmbH; Bristol-Myers Squibb; Lilly; MCI Group
Research Funding - AstraZeneca; Bristol-Myers Squibb; Celgene; Eurozyto; Federal Ministry of Education and Research; German Cancer Aid; German Research Foundation; Hospira; Immutep; Ipsen; Lilly; Medac; MSD Sharp & Dohme; Roche; Sanofi; Vifor Pharma